Health care sectors are transitioning from a fee-for-service payment system to new value-based payment models, and a new business model known as Clinical Lab 2.0 is leading the way. Clinical Lab 2.0 aims to support the transition of the US health care system from sick care to well care by providing meaningful interpretation of the clinical laboratory data. By delivering critical information in an actionable way, laboratorians can help optimize the diagnosis, treatment, and monitoring of patients while improving outcomes.requirements of the situation and shift their focus to those specific areas. In addition, crisis requires even more clear and precise communication than normal. It also requires leaders to be more open to feedback and help, to effectively take advantage of all the knowledge and experience in the team.
Available On Demand Now
Professor and Vice Chair of
Population Health, Department of Pathology and Laboratory Medicine
University of Vermont Health Network
Clinical Pathology Informatics and Quality
Geisinger Medical Laboratories
Donna Wolk Division Director Geisinger
Diagnostic Medicine Institute
Rick VanNess Product Management -
TriCore Reference Laboratories
This webinar will provide you with background and tips on transitioning your lab from Clinical 1.0 to Clinical 2.0:
What is Clinical Lab 2.0?
Understanding the need for Clinical Lab 2.0
External forces impacting labs
How to demonstrate the value of your lab
Hear from labs participating in Clinical Lab 2.0
Register Now for the On Demand Webinar
Clinical Lab 2.0 Webinar Registration
Binding Site is leading the way in special protein diagnostics with Freelite® serum free light chain assays, the market-leading and guideline-recommended free light chain test, and Optilite®, the smart solution for special protein testing. In addition to a menu of assays for the investigation of immune status, including Beta-2 microglobulin and CSF assays, Binding Site gives clinicians and laboratory staff the tools to significantly improve diagnosis and management of patients across a range of cancers and immune system disorders.
Lab Manager c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States,19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: firstname.lastname@example.org